生物資訊服務市場：按服務類型、應用程式、工作流程、部署模式、最終用戶和地區分類

預計到2026年，生物資訊服務市場規模將達到42.7億美元，到2033年將達到111.4億美元。預計從2026年到2033年，該市場將以14.7%的複合年成長率成長。

全球生物資訊服務市場是一個快速發展的領域，它彌合了生物科學與資訊科技之間的鴻溝，促進了複雜生物數據的收集、分析和解讀。生物資訊服務涵蓋了一套全面的計算工具和調查方法，旨在支持製藥、生物技術、學術和醫療機構進行基因組學、蛋白質組學、轉錄組學和代謝體學研究。這些服務包括序列分析、結構分析、分子建模、通路分析和資料庫管理，使研究人員能夠加速藥物發現、實現個人化醫療並推動精準醫療舉措。

受基因組數據量激增、定序成本下降以及雲端解決方案日益普及的推動，生物資訊市場正經歷前所未有的成長。領先的服務供應商在資料探勘、演算法開發和建立客製化生物資訊學流程方面擁有豐富的專業知識，為從農業生物技術到臨床診斷等各種應用提供支援。人工智慧 (AI) 和機器學習技術的融合進一步增強了生物資訊服務處理大量資料集和提取重要生物學見解的能力，使該市場成為現代生命科學研發和治療方法開發的關鍵驅動力。

市場動態

全球生物資訊服務市場受多種關鍵因素驅動，這些因素共同推動該市場在眾多領域的強勁擴張。其中一個主要成長要素是次世代定序技術帶來的基因組資料指數級成長，從而催生了對先進運算分析和解讀服務的空前需求。除了DNA定序成本的下降，各國政府支持基因組研究和精準醫療計畫的措施也提高了全球學術機構和醫療機構取得基因組技術的機會。此外，慢性病盛行率的上升以及對個人化醫療方法的日益重視，正在加速生物資訊服務在藥物研發和臨床研究中的應用。

然而，生物資訊市場面臨著許多限制因素，包括先進生物資訊學基礎設施的高成本、熟練的計算生物學家短缺以及複雜的資料隱私和跨境資料共用法律法規。資料安全問題以及生物資訊學工作流程缺乏標準化協議進一步阻礙了市場成長，尤其是在臨床和商業應用領域。儘管存在這些限制因素，但人工智慧 (AI) 和機器學習技術與生物資訊學平台的日益融合，賦予了其更先進的數據分析能力，從而創造了巨大的成長機會。生物資訊學在農業生物技術、環境監測和法醫學等領域的廣泛應用預示著其前景盈利。同時，基於雲端的生物資訊解決方案的日益普及，為運算資源有限的機構提供了一種擴充性且經濟高效的替代方案，最終推動了市場的民主化和可及性的提升。

本次調查的主要特點

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究基於以下參數分析了全球生物資訊服務市場的主要參與者：公司亮點、產品系列、關鍵亮點、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球生物資訊服務市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過對全球生物資訊服務市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球生物資訊服務市場：依服務類型分類，2021-2033年

• 序列分析服務
• 蛋白質體學分析服務
• 基因表現和功能分析服務
• 生物標記發現服務
• 臨床生物資訊服務
• 化學資訊學和藥物發現服務
• 資料管理和儲存服務
• 統計和計算建模服務

第5章 全球生物資訊服務市場：依應用領域分類，2021-2033年

• 基因組學
• 蛋白質體學
• 轉錄組學
• 代謝體學和脂類組學
• 藥物發現和藥物開發
• 精準醫療
• 農業調查
• 環境調查

第6章 全球生物資訊服務市場：依工作流程分類，2021-2033年

• 預處理工作流程
• 主要分析工作流程
• 二次分析工作流程
• 三階分析工作流程

第7章 全球生物資訊服務市場：依部署模式分類，2021-2033年

• 現場
• 基於雲端的

第8章 全球生物資訊服務市場：依最終用戶分類，2021-2033年

• 製藥和生物技術公司
• 學術研究機構
• 醫院和臨床診斷檢查室
• 農業與環境研究所
• 受託研究機構（CRO）

第9章 全球生物資訊服務市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第10章 競爭格局

• Illumina
• QIAGEN
• BGI Genomics
• Thermo Fisher Scientific
• F Hoffmann La Roche
• PerkinElmer
• Agilent Technologies
• Eurofins Scientific
• Bio Rad Laboratories
• GENEWIZ
• DNAnexus
• Fios Genomics
• Seven Bridges Genomics
• Charles River Laboratories
• Labcorp

第11章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第12章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Bioinformatics Services Market is estimated to be valued at USD 4.27 Bn in 2026 and is expected to reach USD 11.14 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.7% from 2026 to 2033.

The global bioinformatics services market represents a rapidly evolving sector that bridges the gap between biological sciences and information technology, facilitating the collection, analysis, and interpretation of complex biological data. Bioinformatics services encompass a comprehensive range of computational tools and methodologies designed to support genomics, proteomics, transcriptomics, and metabolomics research across pharmaceutical, biotechnology, academic, and healthcare institutions. These services include sequence analysis, structural analysis, molecular modeling, pathway analysis, and database management, enabling researchers to accelerate drug discovery, personalize medicine approaches, and advance precision healthcare initiatives.

The market has experienced unprecedented growth driven by the exponential increase in genomic data generation, declining sequencing costs, and rising adoption of cloud-based solutions. Key service providers offer specialized expertise in data mining, algorithm development, and custom bioinformatics pipeline creation, supporting diverse applications from agricultural biotechnology to clinical diagnostics. The integration of artificial intelligence and machine learning technologies has further enhanced the capability of bioinformatics services to process vast datasets and extract meaningful biological insights, positioning this market as a critical enabler of modern life sciences research and therapeutic development.

Market Dynamics

The global bioinformatics services market is propelled by several key drivers that collectively fuel its robust expansion across multiple sectors. The primary growth driver stems from the exponential increase in genomic data generation through next-generation sequencing technologies, creating an unprecedented demand for sophisticated computational analysis and interpretation services. The declining costs of DNA sequencing, coupled with government initiatives supporting genomics research and precision medicine programs, have democratized access to genomic technologies across academic institutions and healthcare organizations worldwide. Additionally, the rising prevalence of chronic diseases and the growing emphasis on personalized medicine approaches have accelerated the adoption of bioinformatics services in drug discovery and clinical research applications.

However, the market faces significant restraints including the high costs associated with advanced bioinformatics infrastructure, shortage of skilled computational biologists, and complex regulatory frameworks governing data privacy and cross-border data sharing. Data security concerns and the lack of standardized protocols for bioinformatics workflows further challenge market growth, particularly in clinical and commercial applications. Despite these constraints, substantial opportunities emerge from the increasing integration of artificial intelligence and machine learning technologies in bioinformatics platforms, enabling more sophisticated data analysis capabilities. The expanding applications of bioinformatics in agricultural biotechnology, environmental monitoring, and forensics present lucrative growth avenues, while the rising adoption of cloud-based bioinformatics solutions offers scalable and cost-effective alternatives for organizations with limited computational resources, ultimately driving market democratization and accessibility.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bioinformatics services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Illumina, QIAGEN, BGI Genomics, Thermo Fisher Scientific, F Hoffmann La Roche, PerkinElmer, Agilent Technologies, Eurofins Scientific, Bio Rad Laboratories, GENEWIZ, DNAnexus, Fios Genomics, Seven Bridges Genomics, Charles River Laboratories, and Labcorp
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global bioinformatics services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioinformatics services market

Market Segmentation

• Service Type Insights (Revenue, USD Bn, 2021 - 2033)
• Sequence Analysis Services
• Proteomics Analysis Services
• Gene Expression and Functional Analysis Services
• Biomarker Discovery Services
• Clinical Bioinformatics Services
• Cheminformatics and Drug Discovery Services
• Data Management and Storage Services
• Statistical and Computational Modelling Services
• Application Insights (Revenue, USD Bn, 2021 - 2033)
• Genomics
• Proteomics
• Transcriptomics
• Metabolomics and Lipidomics
• Drug Discovery and Development
• Precision Medicine
• Agricultural Research
• Environmental Research
• Workflow Insights (Revenue, USD Bn, 2021 - 2033)
• Pre-Processing Workflow
• Primary Analysis Workflow
• Secondary Analysis Workflow
• Tertiary Analysis Workflow
• Deployment Model Insights (Revenue, USD Bn, 2021 - 2033)
• On-Premise
• Cloud-Based
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Hospitals and Clinical Diagnostic Laboratories
• Agricultural and Environmental Testing Laboratories
• Contract Research Organizations (CROs)
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Illumina
• QIAGEN
• BGI Genomics
• Thermo Fisher Scientific
• F Hoffmann La Roche
• PerkinElmer
• Agilent Technologies
• Eurofins Scientific
• Bio Rad Laboratories
• GENEWIZ
• DNAnexus
• Fios Genomics
• Seven Bridges Genomics
• Charles River Laboratories
• Labcorp

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Bioinformatics Services Market, By Service Type
  • Global Bioinformatics Services Market, By Application
  • Global Bioinformatics Services Market, By Workflow
  • Global Bioinformatics Services Market, By Deployment Model
  • Global Bioinformatics Services Market, By End User
  • Global Bioinformatics Services Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Bioinformatics Services Market, By Service Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Sequence Analysis Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Proteomics Analysis Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Gene Expression and Functional Analysis Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Biomarker Discovery Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Clinical Bioinformatics Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cheminformatics and Drug Discovery Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Data Management and Storage Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Statistical and Computational Modelling Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Bioinformatics Services Market, By Application, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Genomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Proteomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Transcriptomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Metabolomics and Lipidomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Precision Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Agricultural Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Environmental Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Bioinformatics Services Market, By Workflow, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Pre-Processing Workflow
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Primary Analysis Workflow
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Secondary Analysis Workflow
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Tertiary Analysis Workflow
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Bioinformatics Services Market, By Deployment Model, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• On-Premise
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cloud-Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Bioinformatics Services Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Hospitals and Clinical Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Agricultural and Environmental Testing Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Bioinformatics Services Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Illumina
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QIAGEN
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BGI Genomics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F Hoffmann La Roche
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PerkinElmer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eurofins Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GENEWIZ
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DNAnexus
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fios Genomics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Seven Bridges Genomics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Labcorp
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us